Molecular, Clinical Features, and Prognostic Implications of PTPN11 Mutation in Adult Patients with Acute Myeloid Leukemia in China

This study highlights the molecular and clinical heterogeneity of PTPN11 mutations in AML, emphasizing their prognostic complexity and the need for integrated molecular profiling. These findings provide valuable insights into the role of PTPN11 mutations and underscore the importance of personalized treatment approaches based on genetic risk stratification.